Furthermore, eight of the genes (COL6A2, EYA4, MYO3A, RUNDC3B, RYR3, SEC14L4, ZNF462, and ZNF502) were highlighted in our previous study as potential markers for clinical outcome in two subtypes of ALL [11]. This evidence concerns the gene MYO3A and acute lymphoblastic leukemia.